From Concept to Commercialization:
How to Take Your Asset to the Next Level

An increasingly large part of innovation is driven by emerging biotech companies who combine knowledge with resources and enthusiasm to embark on the long winding road of drug development.

In today’s hypercompetitive landscape, it takes more than scientific expertise and experience with ever-changing health authority expectations to achieve long-term success. The ability to successfully navigate regulatory, clinical and commercial complexities is vital to achieving your end goals.

This session will focus on best practices for emerging biotech companies when working towards phase I proof of concept, preparing for regulatory review, communicating effectively with health authorities and exploring funding in support of sustained growth.

Topics for discussion include:

  • Equipping biotech companies with constructive tools for partnering, demonstrated with real world examples
  • Exploring critical insights into venture capital and large pharma criteria for investment
  • Key considerations for maximizing success with regulatory agencies
  • Optimal use of US and EU Expedited Drug Development and Marketing Application Review Programs
  • Recommended use of health economic modelling to evaluate value and value drivers
  • How to plan evidence generation to meet payer requirements
PAREXEL speakers to include:

  • Former EMA & MHRA regulatory experts
  • Market access consultants
  • Health Advances strategic development partners

Presentations will take place from 10:00 a.m. – 12:00 p.m. Lunch will be served following the presentation. To register, please complete the information below. You also have the option to meet with one of our subject-matter experts after the presentation.

Day of Week Date Location
Tuesday March 12th Paris, France: PAREXEL International France, 190 Rue Championnet, 75018 Paris, France
Thursday March 14th Barcelona, Spain: Parc Científic de Barcelona, C/ Baldiri Reixac, 4-8, 08028 Barcelona
Tuesday March 26th Leiden, Netherlands: City Resort Leiden, Bargelaan 180, 2333 CW, Leiden
Wednesday March 27th London, England: 30 Euston Square, London, NW1 2FB
Tuesday April 2nd Stockholm, Sweden: Konferens Spårvagnshallarna, Birger Jarlsgatan 57A, 113 81 Stockholm
Thursday April 4th Copenhagen, Denmark: Copenhagen Bio Science Park, Ole Maaløes Vej 3, 2200 København N